Fengzhi Li

Fengzhi Li

uStartups Member since November 15, 2012
Basic Information
Name Fengzhi Li
Birthdate November 30, -0001
Bio Dr. Li is the founder and Chief Scientific Officer (CSO) of the Canget BioTekpharma company (www.canget-biotek.com). The research in his academic laboratory has been supported by federal agencies (NIH/NCI, DOD) and various public/private foundations. Dr. Li has been initially involved in the characterization of the antiapoptotic survivin gene and is one of the top leading scientists in the survivin research field. In the past decade, he has developed an outstanding scientific career and published over 50 peer-reviewed articles in the drug resistance and anti-apoptosis cancer research field relevant to the inhibitor of apoptosis (IAP) and Bcl-2 family proteins. He was reported to be in the top 5% of cited authors for the Journals relevant to Biology and Biochemistry.
Gender male
Contact Information
State New York
City New York
Country United States
Personal website or linked in http://www.roswellpark.edu/fengzhi-li
Universities Attended
Education
Year graduated 1992